Solarea Bio, Inc., 2025-11-20
An SEC Form D private-offering notice from Waltham, MA, an undisclosed offering target in Biotech. Filed 2025-11-20. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing microbiome-derived, food-based therapies for age-related conditions, including a synbiotic medical food for postmenopausal bone loss.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Kamal Therapeutics, Inc., 2025-11-24, $17.3M, Hingham, MA
- RPT Labworks, Inc., 2025-11-21, $3M, Oregon, WI
- anyvoice Inc., 2025-11-24, $50M, Boston, MA
- Conexeu Sciences Inc., 2025-11-20, $202K, Reno, NV
- VoiceRun, Inc., 2025-11-21, $5.5M, Cambridge, MA
- ECLIPSE BIOINNOVATIONS, INC., 2025-11-20, $7.2M, San Diego, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.